ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 4 USDMF, 3 NDC API, 2 VMF, 7 Listed Suppliers

9 API Suppliers
4 USDMF
3 NDC API
2 VMF
7 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 DKSH, 1 Jai Radhe Sales, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 3 DFE Pharma, 2 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 3 Kerry, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 8 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders, 17 Thickeners and Stabilizers, 14 Direct Compression, 14 Topical, 14 Disintegrants & Superdisintegrants, 11 Lubricants & Glidants, 8 Co-Processed Excipients, 7 Granulation, 6 Emulsifying Agents, 5 Rheology Modifiers, 4 Controlled & Modified Release, 3 Film Formers & Plasticizers, 3 Solubilizers, 2 Taste Masking, 2 Chewable & Orodispersible Aids, 2 Coating Systems & Additives, 2 Parenteral, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 1 Finished Drug Prices

globalSalesInformation
2 US Medicaid Prescriptions
1 Finished Drug Prices

MARKET PLACE

9 APIs

marketPlace
9 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 1 US Exclusivities, 6 Health Canada Patents

patents
1 US Patents
1 US Exclusivities
6 Health Canada Patents

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

301,874

Annual Reports (USD Million)

Finished Drug Prices

79 RELATED EXCIPIENT COMPANIES

138EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Spinosad factor d, 131929-63-0, A 83543d, Chebi:9232, 78g4631rtt, (1s,2s,5r,7s,9s,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione

Molecular Formula

C₄₂H₆₇NO₁₀

Molecular Weight

746.0 g/mol

InChI Key

RDECBWLKMPEKPM-PSCJHHPTSA-N

FDA UNII

78G4631RTT

spinosyn D is a natural product found in Gossypium with data available.

1 2D Structure

Spinosyn D

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(1S,2S,5R,7S,9S,10S,14R,15S,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione

2.1.2 InChI

InChI=1S/C42H67NO10/c1-11-26-13-12-14-35(53-37-16-15-34(43(6)7)24(4)49-37)23(3)38(45)33-20-31-29(32(33)21-36(44)51-26)17-22(2)28-18-27(19-30(28)31)52-42-41(48-10)40(47-9)39(46-8)25(5)50-42/h17,20,23-32,34-35,37,39-42H,11-16,18-19,21H2,1-10H3/t23-,24-,25+,26+,27-,28+,29-,30-,31-,32+,34+,35+,37+,39+,40-,41-,42+/m1/s1

2.1.3 InChI Key

RDECBWLKMPEKPM-PSCJHHPTSA-N

2.1.4 Canonical SMILES

CCC1CCCC(C(C(=O)C2=CC3C4CC(CC4C(=CC3C2CC(=O)O1)C)OC5C(C(C(C(O5)C)OC)OC)OC)C)OC6CCC(C(O6)C)N(C)C

2.1.5 Isomeric SMILES

CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C

2.2 Other Identifiers

2.2.1 UNII

78G4631RTT

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Spinosyn-d

2.3.2 Depositor-Supplied Synonyms

1. Spinosad Factor D

2. 131929-63-0

3. A 83543d

4. Chebi:9232

5. 78g4631rtt

6. (1s,2s,5r,7s,9s,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione

7. (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-13-{[(2r,5s,6r)-5-(dimethylamino)-6-methyltetrahydro-2h-pyran-2-yl]oxy}-9-ethyl-4,14-dimethyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1h-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranoside

8. 1h-as-indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-o-methyl-.alpha.-l-mannopyranosyl)oxy-13-(2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2

9. Spinosad Factor D [usan]

10. Unii-78g4631rtt

11. Spinosyn D [mi]

12. Schembl465825

13. Chembl503450

14. Dtxsid3037599

15. Zinc85537011

16. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimet

17. Xs175291

18. J-006090

19. Q27108325

20. (2r,3as,5ar,5bs,9s,13s,14r,16as,16br)-2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-4,14-dimethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione

21. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o- Methyl-a-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5- (dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl- 2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-

22. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₄₂H₆₇NO₁₀
Molecular Weight	746.0 g/mol
XLogP3	4.8
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	11
Rotatable Bond Count	9
Exact Mass	745.47649733 g/mol
Monoisotopic Mass	745.47649733 g/mol
Topological Polar Surface Area	111 Å²
Heavy Atom Count	53
Formal Charge	0
Complexity	1330
Isotope Atom Count	0
Defined Atom Stereocenter Count	17
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

VMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Thickeners and Stabilizers

Direct Compression

Topical

Disintegrants & Superdisintegrants

Lubricants & Glidants

Co-Processed Excipients

Granulation

Emulsifying Agents

Rheology Modifiers

Controlled & Modified Release

Film Formers & Plasticizers

Solubilizers

Taste Masking

Chewable & Orodispersible Aids

Coating Systems & Additives

Parenteral

API Stability Enhancers

Surfactant & Foaming Agents

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Health Canada Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

List of Suppliers' Api Stability Enhancers Excipients Application used in Spinosyn D on PharmaCompass.com

Spinosyn D

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers

4 USDMF

3 NDC API

2 VMF

7 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers

1 FDA Orange Book

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

4 DKSH

1 Jai Radhe Sales

7 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Actylis

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

3 DFE Pharma

2 Finar

4 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

3 Kerry

7 Microlex e.U

1 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

8 Roquette

1 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders

17 Thickeners and Stabilizers

14 Direct Compression

14 Topical

14 Disintegrants & Superdisintegrants

11 Lubricants & Glidants

8 Co-Processed Excipients

7 Granulation

6 Emulsifying Agents

5 Rheology Modifiers

4 Controlled & Modified Release

3 Film Formers & Plasticizers

3 Solubilizers

2 Taste Masking

2 Chewable & Orodispersible Aids

2 Coating Systems & Additives

2 Parenteral

1 API Stability Enhancers

1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

1 Finished Drug Prices

MARKET PLACE

9 APIs

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Exclusivities

6 Health Canada Patents

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES